Literature DB >> 23227999

Effect of treatment for paediatric cancers on balance: what do we know? A review of the evidence.

M Turner1, D Gagnon, M Lagace, I Gagnon.   

Abstract

This review aims to explore the literature investigating balance outcomes in survivors of childhood cancer. A structured search of five databases resulted in 16 articles included in this review. Nearly all were classified as Level 4 evidence using the updated Oxford Centre for Evidence-Based Medicine Levels of Evidence. Balance abilities have been investigated solely in survivors of acute lymphoblastic leukaemia or central nervous system tumours. The literature tends to support the idea that survivors present with balance difficulties but the results need to be closely scrutinised. Several studies report results using the same experimental group, while other studies use balance outcome measures that have not had their psychometric properties assessed with this population. There are also few studies that evaluate dynamic balance abilities in survivors of paediatric cancers, which may be more influential on functional tasks. Furthermore, very few of the included studies investigate how the found balance deficits affect this population's daily lives, which would be necessary in order to determine if intervention should be geared towards this area. Directions for future research should also include multi-centred, clinically oriented trials to evaluate balance abilities in survivors of childhood cancers compared with healthy control subjects in order to strengthen the literature.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 23227999     DOI: 10.1111/ecc.12019

Source DB:  PubMed          Journal:  Eur J Cancer Care (Engl)        ISSN: 0961-5423            Impact factor:   2.520


  4 in total

1.  Balance impairment in survivors of pediatric brain cancers: risk factors and associated physical limitations.

Authors:  Mitra Varedi; Lu Lu; Nicholas S Phillips; Robyn E Partin; Tara M Brinkman; Gregory T Armstrong; Emma Chase; Raja B Khan; Douglas Powell; Raymond F McKenna; Leslie L Robison; Melissa M Hudson; Kirsten K Ness
Journal:  J Cancer Surviv       Date:  2020-09-07       Impact factor: 4.442

Review 2.  Targeted nanoparticles for pediatric leukemia therapy.

Authors:  Riyaz Basha; Nirupama Sabnis; Kenneth Heym; W Paul Bowman; Andras G Lacko
Journal:  Front Oncol       Date:  2014-05-13       Impact factor: 6.244

Review 3.  Nanotechnology and Pediatric Cancer: Prevention, Diagnosis and Treatment.

Authors:  H Zare-Zardini; A Amiri; M Shanbedi; A Taheri-Kafrani; Z Sadri; F Ghanizadeh; H Neamatzadeh; R Sheikhpour; F Keyvani Boroujeni; R Masoumi Dehshiri; A Hashemi; M M Aminorroaya; M R Dehgahnzadeh; Sh Shahriari
Journal:  Iran J Ped Hematol Oncol       Date:  2015-12-10

4.  Motor performance after treatment of pilocytic astrocytoma in the posterior fossa in childhood.

Authors:  Ingela Kristiansen; Gunilla E Frykberg; Anette Höglund; Annette Sondell; Bo Strömberg; Per Frisk
Journal:  Cancer Rep (Hoboken)       Date:  2021-10-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.